Home › NCT04875884

Optimized MRI of Patients With Hip Arthroplasty

Who can join

Ages 18 to 99 · All sexes

Inclusion Criteria:

* Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
* Referred for MRI examination at the discretion of the treating physician
* Provision of signed and dated informed consent form
* No metal hardware in the body including contralateral hip arthroplasty
* No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices

Exclusion Criteria:

* History of revision hip arthroplasty
* Pregnancy (self-reported, or self-suspected)
* Hip arthroplasty surgery within one year of enrollment
* Clinical indication to administer intravenous contrast material during MRI

About the study

This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.

What is being tested

• Modified MRI (device)

Sponsor: NYU Langone Health · Participants: 22 · Started: Aug 11, 2022

Contact the study team

• Iman Khodarahmi, MD · Phone: 212-263-1379

Official record on ClinicalTrials.gov — NCT04875884

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.